The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
This study seeks to exploit bladder cannabidiol receptors as a therapeutic drug target by conducting a double-masked, placebo-controlled randomized trial evaluating the effects of vaginal hemp cannabidiol (CBD) suppositories on lower urinary tract symptoms (LUTS), pain severity, and sexual function.
Epistemonikos ID: c36ae8879d8179a1f71bdfb6cd0f9b0d1274e526
First added on: Dec 20, 2022